Long COVID Research Moonshot Act
Latest Action
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Long COVID Research Moonshot Act (H.R. 9907) is a legislative proposal introduced in the 118th Congress aimed at advancing research on Long COVID, a condition characterized by persistent symptoms following acute COVID-19 infection. The bill was referred to the House Committees on Energy and Commerce and Education and the Workforce for consideration. However, the bill ultimately failed or expired without further legislative action. No official summary or full text is available, limiting detailed analysis of specific provisions.
H.R. 9907 sought to promote research into Long COVID but did not progress beyond committee referral and expired without enactment.
- The bill focuses on Long COVID research within the health policy area.
- It was referred to two House committees for jurisdictional review but received no further action.
- The bill status is marked as failed or expired, indicating it did not become law.
['Individuals suffering from Long COVID who may benefit from enhanced research and understanding of the condition.', 'Health research agencies and institutions potentially involved in Long COVID studies.', 'Healthcare providers and public health organizations focused on post-COVID conditions.']
['Lack of available full bill text and official summary limits clarity on funding, authority, and specific research directives.', 'Failure to advance past committee referral suggests possible challenges in legislative prioritization or consensus.', 'Without enacted provisions, there is no established oversight or implementation framework.']
The bill was introduced in the House during the 118th Congress and referred to relevant committees for consideration. The referral to the Committee on Energy and Commerce and the Committee on Education and the Workforce reflects the jurisdictional overlap in health research and workforce implications. The bill did not advance beyond committee referral and expired, indicating it did not receive sufficient legislative support or prioritization during the session.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
["Potential increased awareness and discussion of Long COVID research needs despite the bill's failure to pass.", 'Possible influence on future legislative efforts or agency initiatives addressing Long COVID.', 'Continued reliance on existing health research frameworks without new mandates or funding from this bill.']
The absence of the full bill text and official summary limits transparency and public understanding of the bill's specific provisions and intended mechanisms. The bill's failure to advance beyond committee referral highlights the importance of tracking legislative progress to assess potential impacts. Future proposals on Long COVID research would benefit from clear documentation and defined oversight provisions to enhance accountability.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.